Repurposing Drugs 
Agenda Day One
Day One: Thursday, January 22
| 8:00 | Conference Registration and Morning Coffee | |
| 8:30 | Chairperson’s Welcome and Opening Remarks Jeffrey McKelvy, PhD, MD, Chief Executive Officer, ITHERX PHARMACEUTICALS | |
| 8:45 |
Scott Reines, MD, PhD, Formerly, Senior VP, JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT | |
| 9:30 | Getting Drugs Off the Shelf and Back Into Development Jeffrey McKelvy, PhD, MD, Chief Executive Officer, ITHERX PHARMACEUTICALS | |
| 10:15 | 30-minute Morning Networking Break in Exhibit Hall | |
| 10:45 |
Dr. Steven Buchsbaum, Deputy Director Discover Strategy, BILL & MELINDA GATES FOUNDATION | |
| 11:30 |
Henry Chesbrough, PhD, Professor & Executive Director, Center for Open Innovation, Haas School of Business, UNIVERSITY OF CALIFORNIA-BERKELEY AND AUTHOR | |
| 12:15 | Networking Lunch | |
| 1:30 | Venture Capitalists’ Perspective on a Viable Repurposing Plan Brett Zbar, Partner, AISLING CAPITAL Art Pappas, Managing Director, PAPPAS VENTURES | |
| 2:15 |
Newell Bascomb, EVP Research and Chief Operating Officer, VICUS THERAPEUTICS | |
| 3:00 | 45-Minute Afternoon Networking Break | |
| 3:45 | Overcome IP Challenges: Risk Mitigation Strategies for Ultimate Success Ted Daley, President, BENNU PHARMACEUTICALS | |
| 4:30 | IP Q&A Panelists: Newell Bascomb, PhD, EVP Research and Chief Operating Officer, VICUS THERAPEUTICS Ted Daley, President, BENNU PHARMACEUTICALS | |
| 5:30-6:30 | Day One Concludes: |
.gif)
Bottom menu
Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved